Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.3153
+0.02237.61%
Post-market: 0.3052-0.0101-3.20%18:36 EDT
Volume:12.67M
Turnover:3.93M
Market Cap:17.60M
PE:-0.49
High:0.3300
Open:0.2910
Low:0.2850
Close:0.2930
52wk High:1.55
52wk Low:0.1952
Shares:55.82M
Float Shares:54.40M
Volume Ratio:0.12
T/O Rate:23.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-4.92
PE(LYR):-0.42

Loading ...

PDS Biotechnology Q1 net loss narrows

Reuters
·
May 13

PDS Biotechnology Q1 EPS USD -0.13

THOMSON REUTERS
·
May 13

PDS Biotechnology Q1 Net Income USD -7.3 Million

THOMSON REUTERS
·
May 13

PDS Biotechnology Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 11

Platinum Active ETFs SPDS and Platinum Trust PDS-PAX

Reuters
·
May 11

PDS Biotech schedules first-quarter results conference call, webcast

Reuters
·
May 06

PDS Biotech signs USD 6 million promissory note financing with YA II PN

Reuters
·
May 02

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 16

PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC

TIPRANKS
·
Apr 15

BUZZ-PDS Biotech jumps on early data for experimental colon cancer drug

Reuters
·
Apr 15

PDS Biotech reports 78% response rate in interim Phase 2 colorectal cancer trial

Reuters
·
Apr 15

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data From Stage 1 of Nci-Led Metastatic Colorectal Cancer (Mcrc) Trial

THOMSON REUTERS
·
Apr 15

B. Riley Securities Sticks to Their Buy Rating for PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 08

Options Volatility and Implied Earnings Moves Today, March 30, 2026

TIPRANKS
·
Mar 30

PDS Biotech FY25 net loss narrows 8.29% to $34.5 million

Reuters
·
Mar 30

Press Release: PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

Dow Jones
·
Mar 30

PDS Biotechnology Corp expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Mar 27

Updated PDS-VIS

Reuters
·
Mar 27

PDS Biotech to Host Conference Call and Webcast for Q4 and Full-Year 2025 Results

Reuters
·
Mar 25